Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
Myotonic dystrophy type 1 (DM1) is associated with aberrant transcript splicing. Here, the authors develop a transgenic mouse model expressing a bi-chromatic reporter system that allows non-invasive monitoring of splicing of a transcript altered in DM1 in vivo, and show that it allows for evaluation...
Saved in:
Main Authors: | Ningyan Hu, Layal Antoury, Timothy M. Baran, Soumya Mitra, C. Frank Bennett, Frank Rigo, Thomas H. Foster, Thurman M. Wheeler |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/b1565fb81d1d487aac6b620c6b16e1b3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies
by: Layal Antoury, et al.
Published: (2018) -
Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy
by: Marzena Wojciechowska, et al.
Published: (2018) -
Epigenetics of Myotonic Dystrophies: A Minireview
by: Virginia Veronica Visconti, et al.
Published: (2021) -
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
by: Fernande Freyermuth, et al.
Published: (2016) -
Cardiac Pathology in Myotonic Dystrophy Type 1
by: Mani S. Mahadevan, et al.
Published: (2021)